CALADRIUS BIOSCIENCES INC - COM NEW (CLBS)

CUSIP: 128058203

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / COM NEW
Total 13F shares
6,670,221
Share change
+4,323,219
Total reported value
$12,872,038
Put/Call ratio
42%
Price per share
$1.93
Number of holders
23
Value change
+$8,623,330
Number of buys
12
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 128058203?
CUSIP 128058203 identifies CLBS - CALADRIUS BIOSCIENCES INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CALADRIUS BIOSCIENCES INC - COM NEW (CLBS) as of Q1 2021

As of 31 Mar 2021, CALADRIUS BIOSCIENCES INC - COM NEW (CLBS) was held by 23 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,670,221 shares. The largest 10 holders included VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., SABBY MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, NORTHERN TRUST CORP, MORGAN STANLEY, DIMENSIONAL FUND ADVISORS LP, and CIBC Private Wealth Group, LLC. This page lists 23 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.